stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Return on equity
AtriCure, Inc.'s return on equity over the twelve months to 30 September 2026 was 2.95%, up 5.4 percentage points from fiscal 2025 (−2.40%). Over the past ten years it has ranged from −18.8% (fiscal 2016) to 11.2% (fiscal 2021); the current reading is higher than 91% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −2.40% | 7.24 |
| FY2024 | −9.64% | (3.04) |
| FY2023 | −6.60% | 3.28 |
| FY2022 | −9.88% | (21.08) |
| FY2021 | 11.2% | 25.80 |
| FY2020 | −14.6% | (0.43) |
| FY2019 | −14.2% | (3.87) |
| FY2018 | −10.3% | 6.02 |
| FY2017 | −16.3% | 2.46 |
| FY2016 | −18.8% | (1.73) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NVST Envista Holdings Corporation compare | 20.5% |
| MMSI Merit Medical Systems, Inc. compare | 9.78% |
| STVN Stevanato Group S.p.A. compare | 9.22% |
| ATRC AtriCure, Inc. | 2.95% |
| ICUI ICU Medical, Inc. compare | 2.79% |
| WRBY Warby Parker Inc. compare | 1.93% |
| MMED MiniMed Group, Inc. compare | 0.00% |
| XRAY DENTSPLY SIRONA Inc. compare | −8.55% |
| PLSE Pulse Biosciences, Inc compare | −60.7% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement